Correlation Between Novo Nordisk and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Novo Nordisk and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Alnylam Pharmaceuticals.
Diversification Opportunities for Novo Nordisk and Alnylam Pharmaceuticals
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Novo and Alnylam is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Novo Nordisk and Alnylam Pharmaceuticals
Considering the 90-day investment horizon Novo Nordisk AS is expected to generate 0.65 times more return on investment than Alnylam Pharmaceuticals. However, Novo Nordisk AS is 1.54 times less risky than Alnylam Pharmaceuticals. It trades about -0.15 of its potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about -0.23 per unit of risk. If you would invest 11,236 in Novo Nordisk AS on August 27, 2024 and sell it today you would lose (730.00) from holding Novo Nordisk AS or give up 6.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Novo Nordisk AS |
| Alnylam Pharmaceuticals |
Novo Nordisk and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and Alnylam Pharmaceuticals
The main advantage of trading using opposite Novo Nordisk and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |